The expression of LCN2 in the liver was highly increased in fatty liver Shionogi (FLS) mouse model (138) which features spontaneous development of fatty liver that progresses to NASH and eventually hepatocellular carcinoma (163, 164). Here, LCN2 is linked to metabolic dysfunction-associated steatohepatitis.